Results 111 to 120 of about 1,478,450 (299)

The intracellular progesterone receptor regulates CD4+ T cells and T cell-dependent antibody responses

, 2013
Grant C. Hughes, Edward A. Clark, Alan H. M. Wong   +2 more
openalex   +2 more sources

A prospective study of the impact of glycaemic status on clinical outcomes and anti-SARS-CoV-2 antibody responses among patients with predominantly non-severe COVID-19

, 2022
David Tak Wai Lui, Y. K. Li, C. H. Lee, Wing-Sun Chow, A. C. H. Lee, Anthony Raymond Tam, Ping Pang, T. Y. Ho, Chung Yeung Cheung, Carol Ho-Yan Fong, K. K. W. To, K. C. B. Tan, Yu Cho Woo, Ivan Fan‐Ngai Hung, K. S. L. Lam   +14 more
openalex   +2 more sources

Strength through diversity: how cancers thrive when clones cooperate

Molecular Oncology, EarlyView.
Intratumor heterogeneity can offer direct benefits to the tumor through cooperation between different clones. In this review, Kuiken et al. discuss existing evidence for clonal cooperativity to identify overarching principles, and highlight how novel technological developments could address remaining open questions.
Marije C. Kuiken, Maartje Witsen, Emile E. Voest, Krijn K. Dijkstra   +3 more
wiley   +1 more source

Novel recombinant BCG coexpressing Ag85B, ESAT-6 and mouse TNF-α induces significantly enhanced cellular immune and antibody responses in C57BL/6 mice [PDF]

, 2010
Hongbo Shen, Chao Wang, Enzhuo Yang, Ying Xu, Wei Liu, Jingran Yan, Feifei Wang, Honghai Wang   +7 more
openalex   +1 more source

Laboratory Based Preliminary Study on Anti-SARS-CoV-2 Antibody Response among State Sector Healthcare Workers in a Single District in Sri Lanka

, 2022
Janaki Abeynayake
openalex   +1 more source

Increased expression of adenosine 2A receptors in metastatic renal cell carcinoma is associated with poorer response to anti-vascular endothelial growth factor agents and anti-PD-1/Anti-CTLA4 antibodies and shorter survival [PDF]

, 2021
Takao Kamai, Toshiki Kijima, Toyonori Tsuzuki, Akinori Nukui, Hideyuki Abe, Kyoko Arai, Ken‐Ichiro Yoshida   +6 more
openalex   +1 more source

Transcriptional network analysis of PTEN‐protein‐deficient prostate tumors reveals robust stromal reprogramming and signs of senescent paracrine communication

Molecular Oncology, EarlyView.
Combining PTEN protein assessment and transcriptomic profiling of prostate tumors, we uncovered a network enriched in senescence and extracellular matrix (ECM) programs associated with PTEN loss and conserved in a mouse model. We show that PTEN‐deficient cells trigger paracrine remodeling of the surrounding stroma and this information could help ...
Ivana Rondon‐Lorefice, Jose I. Lopez, Aitziber Ugalde‐Olano, Maite Zufiaurre, Ianire Astobiza, Natalia Martin‐Martin, Laura Bozal‐Basterra, Saioa Garcia‐Longarte, Amaia Zabala‐Letona, Sofia Rey, Aida Santos‐Martin, Miguel Unda, Ana Loizaga‐Iriarte, Mariona Graupera, Paolo Nuciforo, Arkaitz Carracedo, Isabel Mendizabal   +16 more
wiley   +1 more source

Factors influencing antibody response after COVID-19 recombinant protein vaccination in adults: A cross-sectional observational study, in Chongqing, China

Human Vaccines & Immunotherapeutics
The factors affecting the antibody responses to the ZF2001 vaccine remain unknown. To address this, we conducted a cross-sectional serological study in the real world.
Jianqiao Li, Jiawei Xu, Yu Liu, Lei Chen, Linling Yu, Xiao Xiao, Qing Wang   +6 more
doaj   +1 more source

Antibody Responses to Natural Rattlesnake Envenomation and a Rattlesnake Toxoid Vaccine in Horses [PDF]

, 2013
Lyndi L. Gilliam, Robert C. Carmichael, Todd C. Holbrook, Jennifer M. Taylor, Charlotte L. Ownby, Dianne McFarlane, Mark E. Payton   +6 more
openalex   +1 more source

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

Molecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute, Júlia Huguet‐Pradell, Jordi Abril‐Fornaguera, Albert Gris‐Oliver, Alex Rialdi, Elisa Fernández‐Martínez, Carla Montironi, Vanessa Del Pozo, Peter Houghton, Laura Zanatto, Agavni Mesropian, Ieva Keraite, Swan Thung, Carolina Armengol, Pau Sancho‐Bru, Ernesto Guccione, Roser Pinyol, Josep M. Llovet   +17 more
wiley   +1 more source